Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.gt.3302291PMID 15292915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of chimeric peptide ligands to galanin receptors and substance P receptors.

  2009cited by this paper
• Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor κB

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB.

  2001cited by this paper
• Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo

  2000cited by this paper
• ASK1 Inhibits Interleukin-1-induced NF-κB Activity through Disruption of TRAF6-TAK1 Interaction*

  2000cited by this paper
• NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts

  2000cited by this paper
• Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

  2000cited by this paper
• Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts

  2000cited by this paper
• Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb

  2000cited by this paper
• Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.

  2000cited by this paper
• The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1beta-stimulated human enterocytes.

  2000cited by this paper
• Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.

  2000cited by this paper
• NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts.

  2000cited by this paper
• The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter*

  1999cited by this paper
• Characterization of a neuronal ?B-binding factor distinct from NF-?B 1 Published on the World Wide W

  1999cited by this paper
• Activators and target genes of Rel/NF-κB transcription factors

  1999cited by this paper
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB.

  1999cited by this paper
• Signal transduction through NF-kappa B.

  1998cited by this paper
• An approach to predicting the stabilities of peptide nucleic acid:DNA duplexes.

  1998cited by this paper
• Inducible Expression of IκBα Repressor Mutants Interferes with NF-κB Activity and HIV-1 Replication in Jurkat T Cells*

  1998cited by this paper
• Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis.

  1998cited by this paper
• Cell penetration by transportan.

  1998cited by this paper
• p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor*

  1998cited by this paper
• Transcription factor decoy for nuclear factor‐κB inhibits tumor necrosis factor‐α‐induced expression of interleukin‐6 and intracellular adhesion molecule‐1 in endothelial cells

  1998cited by this paper
• Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function.

  1998cited by this paper
• Decoy Administration of NF-κB into the Subarachnoid Space for Cerebral Angiopathy

  1998cited by this paper
• MyD88, an Adapter Protein Involved in Interleukin-1 Signaling*

  1998cited by this paper
• Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells.

  1998cited by this paper
• Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis*

  1998cited by this paper
• Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

  1998cited by this paper
• Signal transduction through NF-κB

  1998cited by this paper
• Inhibition of nuclear factor kappa B (NFκB) activity induces nerve growth factor‐resistant apoptosis in PC12 cells

  1997cited by this paper
• Identification and Characterization of an IκB Kinase

  1997cited by this paper
• NF-kappa B: a crucial transcription factor for glial and neuronal cell function.

  1997cited by this paper
• Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells.

  1997cited by this paper
• Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains.

  1997cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

  1997cited by this paper
• Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells*

  1997cited by this paper
• Nuclear translocation of NF‐κB in cholinergic neurons of patients with Alzheimer's disease

  1997cited by this paper
• Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique.

  1997cited by this paper
• Identification and characterization of an IkappaB kinase.

  1997cited by this paper
• NF-kB: a crucial transcription factor for glial and neuronal cell function

  1997cited by this paper
• IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK

  1997cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.

  1996cited by this paper
• Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease

  1996cited by this paper
• The κB Enhancer of the Human Interleukin-6 Promoter Is Necessary and Sufficient to Confer an IL-1β and TNF-α Response in Transfected Human Cell Lines: Requirement for Members of the C/EBP Family for Activity

  1996cited by this paper
• Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.

  1996cited by this paper
• The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.

  1996cited by this paper
• Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway

  1996cited by this paper
• Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

  1995cited by this paper
• Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*)

  1995cited by this paper
• Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-B (*)

  1995cited by this paper
• Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

  1995cited by this paper
• Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].

  1995cited by this paper
• The third helix of the Antennapedia homeodomain translocates through biological membranes.

  1994cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1.

  1994cited by this paper
• Structural and functional analysis of NF-kappa B. Determinants of DNA binding specificity and protein interaction.

  1994cited by this paper
• Inflammatory mechanisms in Alzheimer's disease.

  1994cited by this paper
• PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cited by this paper
• N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65

  1993cited by this paper
• Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993cited by this paper
• Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6.

  1993cited by this paper
• Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein

  1992cited by this paper
• Peptide nucleic acids (PNA) : oligonucleotide analogues with an achiral peptide backbone

  1992cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein.

  1992cited by this paper
• Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

  1992cited by this paper
• Complement activation by beta-amyloid in Alzheimer disease.

  1992cited by this paper
• Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation

  1992cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

  1990cited by this paper
• Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

  1990cited by this paper
• Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta.

  1989cited by this paper
• I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

  1988cited by this paper

• The Correlation Between PINK-1/Parkin Mediated Mitophagy, Endoplasmic Reticulum Stress and Total Polyamines in Pediatric Bronchial Asthma: An Integrated Network of Pathways

  2021cites this paper
• Cell-Penetrating Peptides and Transportan

  2021cites this paper
• Role of charge and hydrophobicity in translocation of cell‐penetrating peptides into Candida albicans cells

  2019cites this paper
• Disulfide bridge as a linker in nucleic acids' bioconjugation. Part II: A summary of practical applications.

  2019cites this paper
• Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs)

  2018cites this paper
• Facile functionalization of peptide nucleic acids (PNAs) for antisense and single nucleotide polymorphism detection.

  2017cites this paper
• Design and examination of potent pseudosubstrate-based oligonucleotide inhibitors against bacterial topoisomerase IV.

  2017cites this paper
• Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination

  2016cites this paper
• Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells

  2016cites this paper
• Cell-penetrating peptides transport therapeutics into cells.

  2015cites this paper
• Potential of peptide-based enhancers for transdermal delivery.

  2015cites this paper
• Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.

  2015cites this paper
• Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

  2014cites this paper
• Engineering Peptide-based Carriers for Drug and Gene Delivery

  2014cites this paper
• Targeting NF-κB subunits p50 and p65 in chroniclymphocytic leukaemia with cell penetrating peptides

  2014cites this paper
• Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.

  2014cites this paper
• Cell-penetrating peptides; chemical modification, mechanism of uptake and formulation development

  2012cites this paper
• Nonviral approach for targeted nucleic acid delivery.

  2012cites this paper
• Cell Penetrating Peptides in the Delivery of Biopharmaceuticals

  2012cites this paper
• Intelligent Drug Delivery Systems for Cancer Therapy

  2012cites this paper
• Focus on NF-κB and C/EBP transcription factors

  2011cites this paper
• Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers

  2011cites this paper
• Cell‐penetrating peptides: Nanocarrier for macromolecule delivery in living cells

  2010cites this paper
• Peptide-based matrices as drug delivery vehicles.

  2010cites this paper
• Noncationic peptides obtained from azurin preferentially enter cancer cells.

  2009cites this paper
• Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

  2009cites this paper
• Chemically modified cell-penetrating peptides for the delivery of nucleic acids

  2009cites this paper
• Targeting transcription factors for therapeutic benefit.

  2008cites this paper
• Cell-Penetrating Peptide-Mediated Delivery of Peptide Nucleic Acid (PNA) Oligomers.

  2008cites this paper
• Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.

  2008cites this paper
• Recent Developments in Peptide-Based Nucleic Acid Delivery

  2008cites this paper
• Cell-penetrating peptides as delivery vehicles for biology and medicine.

  2008cites this paper
• Targeting cytokine expression in glial cells by cellular delivery of an NF-κB decoy

  2007cites this paper
• Applications of cell-penetrating peptides in regulation of gene expression.

  2007cites this paper
• Vectorization of oligonucleotides with cell-penetrating peptides

  2007influential citation
• INVESTIGATION OF THE MECHANISM AND THERAPEUTIC POTENTIAL OF A TRANSCRIPTION FACTOR DECOY TARGETING SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-3 (STAT3) FOR SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)

  2007cites this paper
• Katioonsete peptiidide rakku sisenemise mehhanismide uurimine

  2007cites this paper
• Design and synthesis of cell-penetrating peptides

  2007cites this paper
• Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.

  2006cites this paper
• 10 Mechanisms of Cargo Delivery by Transportans

  2006cites this paper
• Biological activity and biotechnological aspects of peptide nucleic acid.

  2006cites this paper
• The engineering of membrane-permeable peptides.

  2005cites this paper
• Cell-penetrating peptides: mechanisms and applications.

  2005cites this paper
• Evaluation of transportan 10 in PEI mediated plasmid delivery assay.

  2005cites this paper
• Cell-penetrating peptides: a comparative membrane toxicity study.

  2005cites this paper
• Cell-penetrating peptides: tools for intracellular delivery of therapeutics

  2005cites this paper
• PNA2/DNA Triplexes: Stability and Specificity

  2005cites this paper
• Cell transduction pathways of transportans.

  2005cites this paper
• Transcription Factor Decoys: A New Model for Disease Intervention

  2005cites this paper
• Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.

  2005cites this paper
• for future therapeutic strategies

  2005cites this paper
• TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.

  2005cites this paper
• Internalisation of cell-penetrating peptides into tobacco protoplasts.

  2005cites this paper
• Cell-penetrating peptides: small from inception to application

  2004cites this paper
• Cell-penetrating peptides and bioactive cargoes : Strategies and mechanisms

  2004cites this paper
• Cell-penetrating peptides: [corrected] from inception to application.

  2004cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net Cell-penetrating Peptide-mediated Therapeutic Molecule Delivery into the Central Nervous System

  year unknowncites this paper
• Cell-penetrating Peptides in Protein Mimicry and Oligonucleotide Delivery Cell-penetrating Peptides in Protein Mimicry and Oligonucleotide Delivery Applications and Mechanisms List of Publications Additional Publications the Transcription Factor C-jun Promotes Ribosomal Rna Processing by Direct Inte

  year unknowncites this paper